Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Med Clin (Barc) ; 74(7): 275-9, 1980 Apr 10.
Article in Spanish | MEDLINE | ID: mdl-6446008

ABSTRACT

Bronchodilator action of two pharmacologically different drugs have been compared. Ipratropium bromide (Sch 1000) is a synthetic atropine derivative and terbutaline sulphate is a beta-stimulating agent. Twelve asthmatic patients and eight patients with chronic bronquitis received terbutaline 0.50 mg. and ipratropium 0.04 mg by aerosol inhalation. Both drugs were given at random on a consecutive-day schedule. All patients were clinically stable before treatment (basal FEV/VC less than 60 percent). Total lung capacity (TLC) forced expiratory volume (FEV), SRaw, and V'/V curves before and at 15, 60, 120, and 240 minutes after the produce administration were registered. Presence of side-effects was also checked. An intensive bronchodilator action was observed either after inhalation of ipratropium bromide or terbutaline, but statistical studies showed no significant differences between both drugs in relation to intensity and duration of their actions. Sch 1000 caused similar bronchodilator effects in all cases; a more intense effect in patients with chronic bronchitis could not be noticed. Evaluation of V'/V curve, and especially its relation to a same pulmonary volume, pointed out that both drugs act upon small respiratory airways. Advance side-effects were not present.


Subject(s)
Asthma/drug therapy , Atropine Derivatives/therapeutic use , Bronchitis/drug therapy , Ipratropium/therapeutic use , Terbutaline/therapeutic use , Aerosols , Bronchodilator Agents/therapeutic use , Clinical Trials as Topic , Drug Evaluation , Humans , Respiration/drug effects , Respiratory Function Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...